Anjarium Biosciences AG

Swiss Startup - Anjarium Biosciences Default Image

Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjariums versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

REGISTER

13.01.2023

Seasoned executives to drive startups in the next phase (startupticker.ch)

30.12.2022

Experienced members on startups' board (startupticker.ch)

16.12.2022

Newly hired executives to boost their company’s growth (startupticker.ch)

20.07.2022

Executive seats taken at six startups (startupticker.ch)

29.06.2022

New C-Suite leaders assume responsibility to boost startup growth (startupticker.ch)

28.01.2022

Schlieren biotech unlocks the potential of gene therapy (startupticker.ch)

16.09.2021

Anjarium Biosciences Raises CHF 55.5 Million Series A Financing (startupticker.ch)

14.09.2020

Strong Swiss delegation at Bio Europe (startupticker.ch)

19.05.2020

Eleven Swiss start-ups on the virtual BIO Digital stage (startupticker.ch)

No milestones

No Jobs

No videos and documents

No Awards

Anjarium Biosciences AG

Website:
www.anjarium.com

Headquarter:
Schlieren

Foundation Date:
June 2016

Technology:

Biotech

Sectors:

Biotech
Drug development platforms
Nano technologies